Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc (ATOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 361,264
  • Shares Outstanding, K 120,824
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,830 K
  • 60-Month Beta 2.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.39
Trade ATOS with:

Options Overview

Details
  • Implied Volatility 145.45%
  • Historical Volatility 146.46%
  • IV Percentile 18%
  • IV Rank 7.77%
  • IV High 582.41% on 12/21/20
  • IV Low 108.66% on 11/10/20
  • Put/Call Vol Ratio 0.19
  • Today's Volume 19,158
  • Volume Avg (30-Day) 98,971
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 419,953
  • Open Int (30-Day) 599,482

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.80 +6.41%
on 07/30/21
7.15 -58.33%
on 07/14/21
-2.39 (-44.52%)
since 07/02/21
3-Month
2.17 +37.30%
on 05/06/21
9.80 -69.60%
on 06/25/21
+0.65 (+27.88%)
since 04/30/21
52-Week
0.81 +267.84%
on 12/17/20
9.80 -69.60%
on 06/25/21
-0.80 (-21.18%)
since 07/31/20

Most Recent Stories

More News
Physician-Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, including evidence of genetic manipulation of the Nipah Virus, a BSL-4 pathogen more lethal than Ebola

/PRNewswire/ -- Physician-Scientist and a group of international scientists have published a pre-print, available , entitled, "CONTAMINATION OR VACCINE RESEARCH? RNA Sequencing data of early COVID-19...

ATOS : 2.95 (-1.34%)
Physician-Scientist Steven Quay and an International Team of Scientists and Investigators Provide Science-Based Analysis of the Origin of COVID-19 to the US Congress

/PRNewswire/ -- An international team of scientists and data analysts, led by Physician-Scientist , MD, PhD, has published a paper entitled, "Science Not Speculation Should Inform the Investigation of...

ATOS : 2.95 (-1.34%)
Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, CLVS, XELA, WIT, and ATOS.

ATOS : 2.95 (-1.34%)
XELA : 2.87 (+9.13%)
CLVS : 4.99 (+3.31%)
AHT : 15.45 (-4.63%)
WIT : 8.43 (+1.20%)
Atossa Therapeutics Receives Regulatory Approval To Open Clinical Study of AT-H201 in Australia

Nebulized formulation being developed to improve lung function in both active-disease COVID-19 patients and "Long Haul" patients with post-infection pulmonary disease

ATOS : 2.95 (-1.34%)
Thinking about buying stock in Provention Bio, Virgin Galactic, Staffing 360 Solutions, Atossa Therapeutics, or Marin Software?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PRVB, SPCE, STAF, ATOS, and MRIN.

ATOS : 2.95 (-1.34%)
STAF : 2.80 (-0.70%)
MRIN : 7.07 (-14.61%)
PRVB : 6.22 (+2.47%)
SPCE : 32.68 (+8.97%)
Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHEK, WISH, MRIN, ATOS, and ALT.

ATOS : 2.95 (-1.34%)
CHEK : 1.1200 (+1.82%)
ALT : 9.33 (+2.87%)
MRIN : 7.07 (-14.61%)
WISH : 10.58 (+6.44%)
Thinking about buying stock in ContextLogic, Atossa Therapeutics, Marin Software, BEST, or BioNano Genomics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WISH, ATOS, MRIN, BEST, and BNGO.

ATOS : 2.95 (-1.34%)
BNGO : 6.14 (+3.54%)
MRIN : 7.07 (-14.61%)
WISH : 10.58 (+6.44%)
BEST : 1.0500 (+3.96%)
Thinking about buying stock in Atossa Therapeutics, ContextLogic, Nokia, Canopy Growth Corp, or Marin Software?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATOS, WISH, NOK, CGC, and MRIN.

CGC : 19.09 (+0.95%)
MRIN : 7.07 (-14.61%)
WISH : 10.58 (+6.44%)
ATOS : 2.95 (-1.34%)
NOK : 6.16 (+1.32%)
Thinking about buying stock in Acasti Pharma, Globalstar, ContextLogic, Atossa Therapeutics, or Ideanomics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACST, GSAT, WISH, ATOS, and IDEX.

IEX : 227.09 (+0.18%)
GSAT : 1.4150 (+2.54%)
IDEX : 2.42 (+2.11%)
WISH : 10.58 (+6.44%)
ACST : 0.4838 (+5.98%)
ATOS : 2.95 (-1.34%)
Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTVT, SCR, BPTH, AVXL, and ATOS.

SCR : 17.51 (+11.88%)
VTVT : 1.9500 (+1.56%)
ATOS : 2.95 (-1.34%)
AVXL : 18.41 (+2.56%)
BPTH : 6.48 (+1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting...

See More

Key Turning Points

3rd Resistance Point 4.46
2nd Resistance Point 4.09
1st Resistance Point 3.54
Last Price 2.95
1st Support Level 2.62
2nd Support Level 2.25
3rd Support Level 1.70

See More

52-Week High 9.80
Fibonacci 61.8% 6.37
Fibonacci 50% 5.31
Fibonacci 38.2% 4.24
Last Price 2.95
52-Week Low 0.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar